Evidence map›Paper›PMID 22310935›Full record

ArticleJournal of assisted reproduction and genetics2012

Pregnancy outcomes in oocyte donation recipients: vaginal gel versus intramuscular injection progesterone replacement.

Brian M Berger, James A Phillips

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Journal of assisted reproduction and genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02772120 (Comparison of Vaginal Progesterone Gel), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02772120 phase4withdrawnnot on this map

Comparison of Vaginal Progesterone Gel (Crinone 8%®) and Intramuscular Progesterone in Vitrified-Warmed Blastocyst Transfer Cycles

TypeinterventionalSponsorBrigham and Women's HospitalEnrolled0ConditionsInfertilityArmsVaginal progesterone gel (Crinone® 8%), Intramuscular Progesterone
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Progesterone: The Key Factor of the Beginning of Life.International journal of molecular sciences · 2022
    Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Progesterone and the luteal phase: a requisite to reproduction.Obstetrics and gynecology clinics of North America · 2015
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brian M BergerBoston IVF, Inc., Waltham, MA 02451, USA. BBerger@BOSTONIVF.com
James A Phillips

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCompare outcomes with vaginal gel versus intramuscular progesterone replacement in donor oocyte recipients.

methodsA single-center retrospective analysis (January 2004-December 2006) evaluated pregnancy outcomes (serum human chorionic gonadotropin, implantation, clinical pregnancy, delivery, total pregnancy loss rates) for 225 recipients of embryos from donor (aged <32 years) oocytes. Vaginal progesterone gel (Crinone® 8%; 90 mg twice daily; n = 105) or intramuscular progesterone (50 mg once daily; n = 120) was started the afternoon of oocyte retrieval and continued until a negative pregnancy test or 10 weeks' gestation.

resultsThere were no statistically significant differences between groups for the five pregnancy outcomes; numerical results favored vaginal progesterone in all cases. Confidence intervals showed vaginal gel was within, or <1% from, a noninferiority limit of 10% versus intramuscular progesterone for four of five pregnancy outcomes.

conclusionsPregnancy outcomes were comparable for progesterone replacement with vaginal gel and intramuscular progesterone in an oocyte donation program.

Indexed as

Embryo TransferHormone Replacement TherapyOocyte DonationAdultChorionic GonadotropinDelayed-Action PreparationsFemaleFertilization in VitroHumansInfertilityInjections, IntramuscularMiddle AgedPregnancyPregnancy OutcomePregnancy RateProgesteroneChorionic GonadotropinCrinoneDelayed-Action PreparationsProgesteroneVaginal Creams, Foams, and Jellies

Identifiers

PMID22310935
PMCPMC3288138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.